Abstract
The first few days post-surgery, patients experience intense pain, hypersensitivity and consequently tend to have minor locomotor activity to avoid pain. Certainly, injury to peripheral tissues produces pain and increases sensitivity to painful (hyperalgesia) and non-painful (allodynia) stimuli. In this regard, preemptive pharmacological treatments to avoid or diminish pain after surgery are relevant. Recent data suggest that the neuropeptide oxytocin when given at spinal cord level could be a molecule with potential preemptive analgesic effects, but this hypothesis has not been properly tested. Using a validated postoperative pain model (i.e. plantar incision), we evaluated in male Wistar rats the potential preemptive antinociceptive effects of intrathecal oxytocin administration measuring tactile hypersensitivity (across 8 days) and spontaneous motor activity (across 3 days). Hypersensitivity was evaluated using von Frey filaments, whereas spontaneous activity (total distance, vertical activity episodes, and time spent in the center of the box) was assessed in real time using a semiautomated open-field system. Under these conditions, we found that animals pretreated with spinal oxytocin before plantar incision showed a diminution of hypersensitivity and an improvement of spontaneous behavior (particularly total distance and vertical activity episodes). This report provides a basis for addressing the therapeutic relevance of oxytocin as a potential preemptive analgesic molecule.
Introduction
Every year, ∽240 million people undergo some type of surgery (; ; ), which causes postoperative pain and distress (e.g. anxiety), and in most cases impairs the patient’s quality life for a brief period (). Aside from postsurgical pain and hypersensitivity, patients submitted to surgical procedures experienced an increased risk (10%–50%) of developing chronic pain (; ). Despite the arsenal of drugs to ameliorate pain during and after these procedures (; ), treatments that prevent (namely preemptive analgesia) the establishment of central sensitization before the surgical incision seem to be a better strategy to ameliorate postsurgical pain (; ). Certainly, as discussed by , if acute postoperative pain is reduced, so is the risk of chronic pain. This idea points to the relevance of preemptive (or perioperative) analgesia in the management of postsurgical pain.
In this context, some studies suggest that spinal oxytocin could have preemptive analgesic effects. Briefly, in preclinical experiments using female rats, showed that after the postpartum period, endogenous spinal oxytocin release seems to diminish the hypersensitivity induced by spinal nerve ligature. Indeed, clinical data showed that the development of chronic pain in women submitted to cesarean is minor in comparison with other non-obstetric interventions (). These data, coupled to fact that spinal oxytocin prevents spinal long-term potentiation (LTP) (), a key process in the development of central sensitization leading to persistent pain (), point out the potential role of oxytocin as a preemptive analgesic. In the last 15 years, studies on the antinociceptive effects of spinal oxytocin have been published (for refs. See ). Briefly, intrathecal (i.t.) oxytocin has been shown to reduce thermal and mechanical hyperalgesia or mechanical allodynia in neuropathic (; ; ) and inflammatory pain models (; ). Most importantly, epidural oxytocin relieves refractory pain in humans ().
Despite the above data suggesting the potential effect of spinal oxytocin as a preemptive analgesic molecule, this hypothesis has not been properly tested in a postoperative experimental pain condition. The present study was designed to preclinically test the preemptive antinociceptive effect of i.t. oxytocin pretreatment before a surgical procedure in a well-established model of postoperative pain. Hence, using the plantar incision model, we analyzed the effect of oxytocin on spontaneous behavior (as a surrogate model of spontaneous pain) or on evoked nociception by von Frey filaments. We found that i.t. pretreatment with oxytocin i) improves spontaneous behavior, ii) improves the recovery time, and iii) diminishes evoked hypersensitivity.
Material and Methods
Experimental Animals
Experiments were performed on 48 adults male Wistar rats weighing 180–220 g. The rats were provided by the bioterium of the Instituto de Neurobiología of the Universidad Nacional Autónoma de Mexico. The animals with free access to food and drinking water were housed in pairs in plastic cages with wood-based bedding, in a controlled temperature (22 ± 2°C) and humidity (50%) room under a 12:12 h light/dark cycle (light beginning at 7:00 h). For evoked pain measurements (von Frey filaments), the experiments were performed between 13:00–15:00 h; for spontaneous behavior, the experiments were performed between 17:00–09:00 h. At the end of the experiments, the animals were halted in a CO2 chamber.
General Procedures
Plantar Incision
As previously described by , gaseous anesthesia with sevoflurane (4–5%; enriched with ¾ N2O and ¼ O2) was delivered with a mask and an incision of the hind paw was performed. Briefly, the plantar aspect of the left hind paw was prepared, and a 1 cm longitudinal incision was made through skin, fascia, and muscle. Under these conditions, the flexor digitorum brevis muscle was elevated and incised. In all cases the surgery was performed between 16:00–16:30 h. The incision started 12 mm distal from the edge of the heel and the skin was closed using 4–0 nylon sutures. Naïve rats underwent a procedure that included anesthesia and sterile preparation of the plantar area, but no incision. Immediately after surgery, the animals were divided into two main sets to evaluate the effects of oxytocin in two behavioral paradigms: i) evoked nociception induced by von Frey filaments and ii) spontaneous behavior using a semiautomated open-field system.
Cutaneous Evoked Nociceptive Responses (von Frey Filaments)
The von Frey filaments were used to measure the magnitude of mechanical hypersensitivity induced by the plantar incision. To assess baseline pain behavior, rats were placed individually on an elevated plastic mesh floor covered with a clear plastic cage top and allowed to acclimate. All rats were pre-tested (1 day before surgery) and tested at 1, 2, 3, 4, 5, 6, 7, and 8 days post-surgery for the response to the withdrawal threshold to von Frey filaments. Briefly, as previously described (), primary withdrawal to punctate stimulation was tested by applying calibrated nylon von Frey monofilaments (Touch-Test™ Sensory Evaluators, North Coast Medical, Inc., CA, USA) to an area adjacent to the incision (near the calcaneus). Each von Frey filament (14, 20, 39, 59, 78, 98, 147, 255, and 588 mN) was applied once, beginning with 14 mN until a withdrawal response occurred, if there was no paw withdrawal, 588 mN was recorded. The withdrawal threshold was calculated from the averaged of three tests.
Assessment of Spontaneous Activity
The rats were behaviorally tested on days 0 (basal), 1 (the same day of surgery), 2, and 3 post-surgical incision. In this case, the surgical incision was made on day 1 and the spontaneous behavior was assessed using the open-field system with arrays of photo-beam sensors to determine the location of the animal in real-time (Omnitech Electronics, Inc., OH, USA). Briefly, animals were placed individually in plexiglass boxes (16 × 16 × 11.75 inches) containing the photo-beam sensors. Locomotor activity and rearing episodes were assessed. The raw data were stored on a computer disk for off-line analyses using the Fusion v5.3 SuperFlex software (Omnitech Electronics, Inc., OH, USA). Under these conditions, spontaneous activity episodes were monitored for 16 h (starting at 17:00 h and ending at 9:00 h the following day) for 4 days. The spontaneous behavior was analyzed during the light phase (17:00–18:00 h) and the dark phase (19:00–07:00 h). In all cases we measured the horizontal activity (total distance), vertical episodes (rearing), and time (seconds) spent in the center of the open-field system. Indeed, horizontal and vertical activity have been proposed as an endpoint to indirectly analyze potential analgesic compounds (; ), whereas time spent in the center has been used as an endpoint to analyze anxiety-related effects (; ), a key issue after postoperative pain (; ; ).
Drug Treatment
Under anesthesia (see above), oxytocin (10 nmol; Sigma-Aldrich, CAS: 50-56-6, base free) or isotonic saline solution (0.9% NaCl) were intrathecally (i.t.) injected in a volume of 20 µl 10 min before the plantar incision. The dose of oxytocin was chosen from previous reports showing that intrathecal oxytocin inhibits nociception in a range of 0.1–10 nmol (; ; ). The i.t. oxytocin or vehicle administration were given in a blinded manner by direct lumbar puncture (22 G) in the L5-L6 intervertebral space following the method described by .
Statistical Analysis
In all cases, statistical difference was considered at p ≤0.01. The data from the von Frey filaments is represented using box and whisker plots or bar graphs [means ± standard error (SE); Figure 1] and were analyzed using the non-parametric Friedman test (Figures 1A–C) or Kruskal-Wallis test (Figure 1D). Furthermore, to compare the global effect of the different treatments, the area under the curve was calculated and analyzed using the parametric one-way analysis of variance (1W-ANOVA; Figure 1E). In the case of spontaneous activity (Figure 3) a Grubb’s test was initially performed to exclude outliers and we graphed the data as means ± SE. To analyze the spontaneous behavior before (basal) and after (day 1) plantar incision, we performed a paired t-test (Figure 3A) for each treatment. In addition, to compare the effect of different treatments for 3 days (Figures 3B–G), the differences were computed by the parametric two-way repeated measures analysis of variance (2W-RM-ANOVA) (in this case sphericity was not assumed). Except for the paired t-test, in all cases, to control the false discovery rate (q = 0.05) for multiple testing, we used the two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli. The statistical analysis results are detailed in Table 1.
Figure 1
Table 1
| Figure | Test | Post hoc comparison |
|---|---|---|
| 1 | Friedman test for multiple comparisons | Benjamini, Krieger and Yekutieli |
| 1A | χ2 = 47.31, n = 6 rats, p < 0.0001 | Basal vs day (D): D1 (<0.0001); D2 (<0.0001); D3 (0.0006); D4 (0.0004); D5 (0.01); D6 (0.05) |
| 1B | χ2 = 47.69, n = 6 rats, p < 0.0001 | Basal vs day (D): D1 (<0.0001); D2 (<0.0001); D3 (0.0002); D4 (0.001); D5 (0.01); D6 (0.06) |
| 1C | χ2 = 45.41, n = 6 rats, p < 0.0001 | Basal vs day (D): D1 (0.001); D2 (0.0003); D3 (0.01); D4 (0.1); D5 (0.6); D6 (>0.99) |
| 1 | Kruskal-Wallis | Benjamini, Krieger and Yekutieli |
| 1D | χ2 = 14.77, n = 6 rats, p < 0.0001 | OXT+Surgery vs V+Surgery, p < 0.0003 |
| 1 | One-way ANOVA | Benjamini, Krieger and Yekutieli |
| 1E | Treatment effect: F(2, 15) = 50.21; p < 0.0001 | OXT+Surgery vs V+Surgery, p < 0.0001 |
| 3 | Two-way RM ANOVA | Benjamini, Krieger and Yekutieli |
| 3B | Interaction: F(9, 60) = 2.272; p = 0.0290 Time effect: F(1.371, 27.42) = 37.18; p < 0.0001 Treatment effect: F(3, 20) = 8.851; p = 0.0006 | Naïve vs Surgery: p at day 1 = 0.003; day 2 < 0.0001; day 3 < 0.001 Naïve vs V+Surgery: p at day 1 = 0.006; day 2 = 0.0004; day 3 = 0.002 Naïve vs OXT+Surgery: p at day 1 = 0.008; day 2 = 0.0001; day 3 = 0.002 V+Surgery vs OXT+Surgery: p at day 1 = 0.429; day 2 = 0.989; day 3 = 0.616 |
| 3C | Interaction: F(9, 60) = 1.789; p = 0.0891 Time effect: F(1.904, 38.02) = 37.18; p < 0.0001 Treatment effect: F(3, 20) = 23.76; p < 0.0001 | Naïve vs Surgery: p at day 1 = 0.001; day 2 = 0.01; day 3 = 0.004 Naïve vs V+Surgery: p at day 1 = 0.001; day 2 = 0.009; day 3 = 0.005 Naïve vs OXT+Surgery: p at day 1 = 0.02; day 2 = 0.2; day 3 = 0.3 V+Surgery vs OXT+Surgery: p at day 1 = 0.005; day 2 = 0.004; day 3 = 0.008 |
| 3D | Interaction: F(9, 60) = 3.439; p = 0.0018 Time effect: F(2.350, 47.01) = 15.43; p < 0.0001 Treatment effect: F(3, 20) = 9.077; p = 0.005 | Naïve vs Surgery: p at day 1 = 0.007; day 2 = 0.02; day 3 = 0.07 Naïve vs V+Surgery: p at day 1 = 0.008; day 2 = 0.03; day 3 = 0.1 Naïve vs OXT+Surgery: p at day 1 = 0.02; day 2 = 0.4; day 3 = 0.09 V+Surgery vs OXT+Surgery: p at day 1 = 0.19; day 2 = 0.031; day 3 = 0.001 |
| 3E | Interaction: F(9, 60) = 4.778; p < 0.0001 Time effect: F(1.930, 38.61) = 17.70; p < 0.0001 Treatment effect: F(3, 20) = 25.14; p < 0.0001 | Naïve vs Surgery: p at day 1 = 0.009; day 2 = 0.002; day 3 = 0.006 Naïve vs V+Surgery: p at day 1 = 0.01; day 2 = 0.002; day 3 = 0.006 Naïve vs OXT+Surgery: p at day 1 = 0.05; day 2 = 0.2; day 3 = 0.1 V+Surgery vs OXT+Surgery: p at day 1 = 0.01; day 2 < 0.0001; day 3 = 0.002 |
| 3F | Interaction: F(9, 60) = 1.85; p = 0.07 Time effect: F(2.77, 55.40) = 2.58; p = 0.067 Treatment effect: F(3, 20) = 1.32; p = 0.29 | Naïve vs Surgery: p at day 1 = 0.224; day 2 = 0.225; day 3 = 0.135 Naïve vs V+Surgery: p at day 1 = 0.206; day 2 = 0.221; day 3 = 0.175 Naïve vs OXT+Surgery: p at day 1 = 0.393; day 2 = 0.789; day 3 = 0.246 V+Surgery vs OXT+Surgery: p at day 1 = 0.25; day 2 = 0.17; day 3 = 0.60 |
| 3G | Interaction: F(9, 60) = 1.073; p = 0.396 Time effect: F(2.324, 46.48) = 0.864; p = 0.442 Treatment effect: F(3, 20) = 8.137; p = 0.001 | Naïve vs Surgery: p at day 1 = 0.394; day 2 = 0.326; day 3 = 0.752 Naïve vs V+Surgery: p at day 1 = 0.647; day 2 = 0.631; day 3 = 0.234 Naïve vs OXT+Surgery: p at day 1 = 0.01; day 2 = 0.06; day 3 = 0.02 V+Surgery vs OXT+Surgery: p at day 1 = 0.01; day 2 = 0.02; day 3 = 0.003 |
Statistical data with their respective post hoc comparison for each figure panel.
In all cases we considered p ≤ 0.01 (underline and bold) for significance.
Results
The Postoperative Pain Model and Evoked Pain
Postoperative pain was induced in animals by plantar incision of the hind paw. Figure 1A shows the primary mechanical withdrawal threshold before (basal; 460 mN) and after plantar incision (for 8 days); note that one day after surgery the withdrawal threshold diminished (36 mN) (p < 0.0001). This hypersensitivity to von Frey filaments remains significant until day 5 post-surgery (p = 0.01). Similar results were obtained in animals pretreated with vehicle (Figure 1B). In contrast, as Figure 1C shows, when the animals received oxytocin (10 nmol, i.t.), the hypersensitivity to von Frey filaments remained significant until day 3 post-surgery (p = 0.01). Note that the withdrawal threshold of naïve animals was not modified during the test days. Furthermore, when comparing the withdrawal threshold of animals pretreated with oxytocin versus untreated animals 1 day after surgery (Figure 1D), we found that the withdrawal threshold of oxytocin-treated rats was higher than that in untreated rats; this result implies a preemptive antinociceptive effect. Similarly, upon analyzing the global effects as area under the curve (AUC) (Figure 1E), we found that oxytocin pretreatment increases the AUC, suggesting that this neuropeptide decreases the evoked hypersensitivity.
Postoperative Pain Model and Spontaneous Behavior
Figure 2 shows the actograms and representative heat map of locomotor activity from naïve (Figure 2A), surgery untreated (Figure 2B), vehicle + surgery (Figure 2C) and oxytocin + surgery (Figure 2D) rats obtained during the 16 h of recording before (basal activity, B) and after (day 1, 2, and 3) surgery. As shown in the actograms, when the animals were first placed in the activity boxes during the light phase (at 17:00 h), they actively explored the novel environment; after this initial exploration, the animals remained with low activity (between 18:00–19:00 h) until the start of the dark phase (lights off at 19:00 h). In the naïve group (Figure 2A), an increase in locomotor activity during the dark phase was clearly observed; this spontaneous activity diminished after surgery in the surgery untreated (Figure 2B) and surgery + vehicle (Figure 2C) groups. Indeed, a visual reduction in the intensity of actograms and heat maps was achieved after surgical incision (see subpanels d1). In contrast, the animals pretreated with oxytocin (Figure 2D) showed a minor impairment of the spontaneous locomotor activity; in fact, at day 3 post-surgery, the locomotor activity and heat map were similar to the basal response.
Figure 2
As shown in Figure 3A, after plantar incision, the total distance traveled and vertical activity tend to diminish in the surgery, vehicle + surgery and oxytocin + surgery groups; this effect is not observed in the naïve animals (p > 0.2). Although similar results were obtained in the time spent in the center during the exploratory hour for naïve, surgery and vehicle + surgery groups, no difference was observed before and after oxytocin treatment (p = 0.929). Also, during the dark phase the probability of finding a difference in the time spent in the center before and after surgery was low in all groups (p > 0.2); nevertheless, the rats receiving oxytocin tended to spend more time in the center (p = 0.073).
Figure 3
When we analyzed the impact of oxytocin treatment in comparison with the other groups, we found that after plantar incision (day 1), the total distance traveled diminished for the first hour of exploratory behavior and for the 12 h of nighttime activity (Figures 3B, C). This impairment was observed throughout the 3 days in the case of surgery and vehicle + surgery group. In contrast, in animals pre-treated with oxytocin, the activity during the dark phase was not statistically different from that of the naïve group (Figure 3C; p ≥ 0.02), even though after surgery a decrease in the distance traveled was found during the first hour of exploratory behavior throughout the 3 days (Figure 3B; p ≤ 0.008).
In the case of vertical activity (Figures 3D, E), at day 1 during light and dark phase, the number of rearing episodes (where the rat stands on its hind legs) was diminished (p ≤ 0.01) only in the groups with surgery or vehicle + surgery but not in the animals treated with oxytocin (p ≥ 0.02). Furthermore, during the dark phase, the vertical activity of the animals without oxytocin was clearly impaired on days 2 and 3 (p ≤ 0.006); interestingly, during the light phase of these days we did not find any statistical differences (p ≥ 0.02) despite the diminution of vertical activity. In animals treated with oxytocin, the number of vertical episodes displayed on days 2 and 3 was similar to that of the naïve group during the light and dark phase (p ≥ 0.09).
Finally, in the case of time spent in the center (Figures 3F, G), the probability that oxytocin affected this variable in comparison with the surgery untreated animals was low on the test days during the exploratory hour (p > 0.2). However, during the dark phase, the animals treated with oxytocin tended to spend more time in the center of the open field, particularly on days 1 and 3 post-surgery.
Discussion
Using a surrogate model of postoperative pain, this study showed that spinal oxytocin pretreatment induces not only a diminution in the evoked mechanical hypersensitivity (Figure 1) but also an improvement of spontaneous activity (Figures 2, 3). Apart from the implications discussed below, these data support our contention that oxytocin could have a potential effect as a preemptive analgesic drug. Furthermore, despite studies about the antinociceptive effect of spinal oxytocin, with perspectives ranging from neuropathic to inflammatory and from behavioral to electrophysiological (see for refs.), we must acknowledge that no study has been performed using a postoperative pain model. This is a key point considering that each paradigm tested in previous reports has specific outcomes that are not interchangeable (). Specifically, postsurgical pain involves lesion of the peripheral tissue, inflammatory process and injury of isolated nerves; hence, the pain induced by surgery is considered an entity apart from other types of pain (; ).
As previously demonstrated (; ; ), paw incision has a remarkable effect on the punctate mechanical induced-hypersensitivity, an effect associated with the sensitization of spinal dorsal horn cells in response to the spontaneous activity of Aδ- and C-fibers (; ). Indeed, as shown in Figure 1, allodynia towards mechanical stimuli occurred after plantar incision, but in animals pretreated with oxytocin (see Figures 1C, D), the impact on the withdrawal threshold on day 1 after surgery was minor, suggesting a preemptive analgesic effect. Specifically, the withdrawal threshold of animals pretreated with this neuropeptide (Figure 1C) was non-statistically different (p = 0.1) to the basal value after four days, whereas the threshold value of untreated animals was not statistically different until day 6 post-surgery (Figures 1A, B; p > 0.05), suggesting that apart from the protective effect observed on day 1, oxytocin also decreases the recovery time. These data correlate with a previous electrophysiological report showing that spinal oxytocin prevents the spinal LTP (), one of the mechanisms whereby acute pain (in this case skin incision) induces central sensitization and consequently long-term hypersensitivity (). We need to mention that the spinal LTP was measured as an increase in the activity of nociceptive Aδ- and C-fibers. Hence, the electrophysiological data about the preemptive antinociceptive effect of oxytocin was translatable to our behavioral experiments measuring mechanical hypersensitivity.
Certainly, to measure allodynia that reflects a better clinical condition, we used the von Frey filaments considering that after surgery, non-noxious stimuli could be the main source of evoked pain (). Nevertheless, although evoked nociceptive tests are useful to evaluate potential analgesics drugs, the measurement of spontaneous behavior is crucial because provides insight into the pain process under “normal” environmental conditions (; ; ; ; ; ). In humans, spontaneous pain can be quantified by asking them (), whereas in rodents the locomotor activity can be analyzed as a surrogate model of this outcome (; ). In addition, the classical stimulus-evoked pain-like behaviors are mainly performed during the light phase of the day, which is when rodents are less active (; ).
In this sense, using an automated system we measured locomotor activity in real time for 16 h, from 17:00 to 09:00 h. When the animals were placed in the activity boxes during the light phase (17:00 h), they actively explored the new environment for approximately 1 h. After initial exploration, most of the animals remained at rest or markedly reduced their activity until the beginning of the dark phase (19:00 h) (for examples see Figure 2). At this point, the animals showed a significant increase in locomotor activity during the night hours (19:00–07:00 h) which decreased once the room light was turned on again (07:00 h). The increase in activity during the day (17:00–18:00 h) is consistent with exploratory behavior in search of possible threats within a new environment (), while the increase in activity immediately after the room darkened (19:00–7:00 h) is consistent with the activity related to drinking, nesting, and exploring the environment to search for food. These observations and studies from several groups (; ; ; ) demonstrate that spontaneous activity is reduced when there is a lesion in the body. Certainly, as discussed by , , , monitoring day/night activity provides an unbiased assessment of discomfort induced by paw incision and, although the common endpoint used to evaluate behavioral hypersensitivity in rodents is mechanical punctate hypersensitivity, few human studies use skin hypersensitivity as a primary endpoint. In this sense, our data using the spontaneous behavior showed that plantar incision decreases the spontaneous behavior (Figures 2, 3).
As previously reported (; ; ), the total distance traveled, and vertical activity were reduced after paw incision in treated and untreated animals (Figure 3A; superior and middle panels). However, when we compared the effect of treatments on the 3 days post-surgery, we found that oxytocin clearly improved the aforementioned variables, particularly during the dark phase (Figures 3B–E; see Table 1 for statistical details). Together, these data support our contention that this neuropeptide could have preemptive analgesic properties, probably by interruption of the spinal LTP () elicited by the plantar incision.
Considering that a previous report () suggested that after plantar incision the animals develop anxiety-like behaviors (using escape-avoidance tests), we decided to analyze the time spent in the center of the cage before and after surgery. As shown in Figure 3A (inferior panels), we found that during the exploratory hour, untreated surgery animals spent less time (p ≤ 0.015) in the center of the cage, but this behavior was not observed in animals treated with oxytocin (p = 0.929). Certainly, under light conditions, anxious animals tend to exhibit minimal exploratory behavior; thus, spending less time in the center is predictable (). Accordingly, during the dark phase we did not find a substantial statistical effect before and after surgery, although a slight increase in this variable was observed in the oxytocin-treated animals (p = 0.073). However, when we compared the effect of treatments for 3 days post-surgery, we observed an increase in the time spent (p ≤ 0.01) in the center during the dark phase in the oxytocin-treated animals.
Collectively, these data suggest that intrathecal oxytocin seems to induce anxiolytic effects, and current evidence shows that oxytocin induces anxiolytic-like effects when given at supraspinal levels (; ). Therefore, the question remains as to how intrathecal oxytocin induces anxiolytic effects. Although the validation of this hypothesis requires additional experiments that fall beyond the scope of the present study, we propose that intrathecal oxytocin could reach supraspinal levels using the cerebrospinal fluid dynamics, thus exerting its anxiolytic effects.
Finally, and considering that we injected oxytocin 10 min before the paw incision, we must to acknowledge that oxytocin when given at central level exerts antinociception between 10 and 90 min after injection (; ; ; ). Certainly, the half-life of this neuropeptide at the central nervous system seems to be nearly 20 min (), which is enough to engage intracellular mechanisms that, in turn, block neuronal sensitization. Although in our study we did not analyze the mechanisms involved in the preemptive effect, evidence has shown that at spinal level, oxytocin blocks the neuronal activity of nociceptive Aδ/C-fibers, an action blocked by oxytocin receptor antagonists (; ; ). Furthermore, as reviewed by and , at spinal dorsal horn level, this neuropeptide recruits mechanisms/circuits associated with a diminution of nociception, for example: i) inhibition of transient potassium current (IA), ii) recruitment or enhancement of GABAergic transmission, and iii) desensitization of spinal TRPV1 channels.
In summary, this study showed that i.t. oxytocin pretreatment given before the incision of the hind paw not only reduces evoked pain-like behaviors but also improves spontaneous behaviors. Taken together, these data support our contention that preoperative i.t. oxytocin administration may be an alternative to provide preemptive analgesia. Further studies focusing on the translational aspects of spinal cord delivery are needed, as well as research about the precise pharmacodynamic/pharmacokinetics aspects of oxytocin effects.
Funding
This research was financially supported by the Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT-UNAM Mexico) under Grant agreement no. IA203119 to AG-H and IN200415 to MC-L, and by the Fondo Sectorial de Investigación para la Educación (CONACyT-Mexico Grant No. A1-S-23631 to AG-H).
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was reviewed and approved by Institutional Animal Care and Use Committee at the Instituto de Neurobiología (UNAM).
Author contributions
AE, GM-L, MC-L, and AG-H designed the experiments. AE made a draft of the manuscript. AG-H was responsible for the overall direction of the project and for editing the manuscript. All authors contributed to the article and approved the submitted version.
Acknowledgments
We acknowledge Deisy Gasca-Martínez for her assistance in the Behavioral Analysis Unit Core Facility of the Instituto de Neurobiología. Also, we thank Jessica González Norris for proofreading the manuscript. The present work is part of the doctoral thesis of Antonio Espinosa De Los Monteros-Zúñiga, a student from Programa de Doctorado en Ciencias Biomédicas (PDCB-UNAM) that received fellowship (no. 326999) from Consejo Nacional de Ciencia y Tecnología (CONACyT-Mexico).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
BrennanT. J.VandermeulenE. P.GebhartG. F. (1996). Characterization of a rat model of incisional pain. Pain64, 493–502. doi: 10.1016/0304-3959(95)01441-1
2
BrennanT. J. (2011). Pathophysiology of postoperative pain. Pain152, S33–S40. doi: 10.1016/j.pain.2010.11.005
3
CarrD. B.GoudasL. C. (1999). Acute pain. Lancet353, 2051–2058. doi: 10.1016/s0140-6736(99)03313-9
4
CastanheiraL.FerreiraM. F.SebastiaoA. M.Telles-CorreiaD. (2018). Anxiety assessment in pre-clinical tests and in clinical trials: a critical review. Curr. Top. Med. Chem.18, 1656–1676. doi: 10.2174/1568026618666181115102518
5
CastelD.SabbagI.NasaevE.PengS.MeilinS. (2018). Open field and a behavior score in PNT model for neuropathic pain in pigs. J. Pain Res.11, 2279–2293. doi: 10.2147/JPR.S172300
6
ChaparroL. E.SmithS. A.MooreR. A.WiffenP. J.GilronI. (2013). Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst. Rev.2013, CD008307. doi: 10.1002/14651858.CD008307.pub2
7
ChapmanC. R.VierckC. J. (2017). The Transition of Acute Postoperative Pain to Chronic Pain: An Integrative Overview of Research on Mechanisms. J. Pain18, 359e1–359e38. doi: 10.1016/j.jpain.2016.11.004
8
ChoH.JangY.LeeB.ChunH.JungJ.KimS. M.et al. (2013). Voluntary Movements as a Possible Non-Reflexive Pain Assay. Mol. Pain9, 25. doi: 10.1186/1744-8069-9-25
9
ChowL. H.ChenY. H.WuW. C.ChangE. P.HuangE. Y. K. (2016). Sex difference in oxytocin-induced anti-hyperalgesia at the spinal level in rats with intraplantar carrageenan-induced inflammation. PloS One11, e0162218. doi: 10.1371/journal.pone.0162218
10
Condés-LaraM.Rojas-PiloniG.Martínez-LorenzanaG.López-HidalgoM.Rodríguez-JiménezJ. (2009). Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells. Brain Res.1247, 38–49. doi: 10.1016/j.brainres.2008.10.030
11
Condés-LaraM.Zayas-GonzálezH.Manzano-GarcíaA.Córdova-QuirozE.Granados-MorteraJ.García-CuevasM.et al. (2016). Successful Pain Management with Epidural Oxytocin. CNS Neurosci. Ther.22, 532–534. doi: 10.1111/cns.12551
12
DeLaTorreS.Rojas-PiloniG.Martínez-LorenzanaG.Rodríguez-JiménezJ.VillanuevaL.Condés-LaraM. (2009). Paraventricular oxytocinergic hypothalamic prevention or interruption of long-term potentiation in dorsal horn nociceptive neurons: electrophysiological and behavioral evidence. Pain144, 320–328. doi: 10.1016/j.pain.2009.05.002
13
DeuisJ. R.DvorakovaL. S.VetterI. (2017). Methods Used to Evaluate Pain Behaviors in Rodents. Front. Mol. Neurosci.10, 284. doi: 10.3389/fnmol.2017.00284
14
EisenachJ. C.PanP.SmileyR. M.Lavand’hommeP.LandauR.HouleT. T. (2013). Resolution of pain after childbirth. Anesthesiology118, 143–151. doi: 10.1097/ALN.0b013e318278ccfd
15
EliavaM.MelchiorM.Knobloch-BollmannH. S.WahisJ.da Silva GouveiaM.TangY.et al. (2016). A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron89, 1291–1304. doi: 10.1016/j.neuron.2016.01.041
16
FileS. E. (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods2, 219–238. doi: 10.1016/01650270(80)90012-6
17
FrankM. G.RubyN. F.HellerH. C.FrankenP. (2017). Development of Circadian Sleep Regulation in the Rat: A Longitudinal Study Under Constant Conditions. Sleep40, zsw077. doi: 10.1093/sleep/zsw077
18
Gaston-JohanssonF.AlbertM.FaganE.ZimmermanL. (1990). Similarities in pain descriptions of four different ethnic-culture groups. J. Pain Symptom Manage.5, 94–100. doi: 10.1016/s0885-3924(05)80022-3
19
Gonzalez-HernandezA.CharletA. (2018). Oxytocin, GABA, and TRPV1, the Analgesic Triad? Front. Mol. Neurosci.11, 398. doi: 10.3389/fnmol.2018.00398
20
González-HernándezA.Espinosa De Los Monteros-ZuñigaA.Martínez-LorenzanaG.Condés-LaraM. (2019). Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model. Exp. Brain Res.237, 2995–3010. doi: 10.1007/s00221-019-05651-7
21
GouldT. D.DaoD. T.KovacsicsC. E. (2009). “The Open Field Test,” in Mood and Anxiety Related Phenotypes in Mice. Ed. GouldT. D. (Totowa, NJ: Humana Press), 1–20. doi: 10.1007/978-1-60761-303-9_1
22
GutierrezS.LiuB.HayashidaK.HouleT. T.EisenachJ. C. (2013). Reversal of peripheral nerve injury-induced hypersensitivity in the postpartum period: role of spinal oxytocin. Anesthesiology118, 152–159. doi: 10.1097/ALN.0b013e318278cd21
23
HämäläinenM. M.GebhartG. F.BrennanT. J. (2002). Acute effect of an incision on mechanosensitive afferents in the plantar rat hindpaw. J. Neurophysiol.87, 712–720. doi: 10.1152/jn.00207.2001
24
ImanakaA.MorinobuS.TokiS.YamamotoS.MatsukiA.KozuruT.et al. (2008). Neonatal tactile stimulation reverses the effect of neonatal isolation on open-field and anxiety-like behavior, and pain sensitivity in male and female adult Sprague–Dawley rats. Behav. Brain Res.186, 91–97. doi: 10.1016/j.bbr.2007.07.039
25
JensenT. S.FinnerupN. B. (2014). Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol.13, 924–935. doi: 10.1016/S1474-4422(14)70102-4
26
KatzJ.SeltzerZ. (2009). Transition from acute to chronic postsurgical pain: risk factors and protective factors. Exp. Rev. Neurother.9, 723–744. doi: 10.1586/ern.09.20
27
KehletH.DahlJ. B. (2003). Anaesthesia, surgery, and challenges in postoperative recovery. Lancet362, 1921–1928. doi: 10.1016/S0140-6736(03)14966-5
28
KehletH.JensenT. S.WoolfC. J. (2006). Persistent postsurgical pain: risk factors and prevention. Lancet367, 1618–1625. doi: 10.1016/S0140-6736(06)68700-X
29
KehletH. (2018). Postoperative pain, analgesia, and recovery-bedfellows that cannot be ignored. Pain159 (S1), S11–S16. doi: 10.1097/j.pain.0000000000001243
30
KouyaF.IqbalZ.CharenD.ShahM.BanikR. K. (2015). Evaluation of anxiety-like behaviour in a rat model of acute postoperative pain. Eur. J. Anaesth.32, 242–247. doi: 10.1097/eja.0000000000000052
31
MajutaL. A.GuedonJ.-M. G.MitchellS. A. T.KuskowskiM. A.MantyhP. W. (2017a). Mice with cancer-induced bone pain show a marked decline in day/night activity. Pain Rep.2, e614. doi: 10.1097/PR9.0000000000000614
32
MajutaL. A.GuedonJ.-M. G.MitchellS. A. T.OssipovM. H.MantyhP. W. (2017b). Anti–nerve growth factor therapy increases spontaneous day/night activity in mice with orthopedic surgery–induced pain. Pain158, 605–617. doi: 10.1097/j.pain.0000000000000799
33
MajutaL. A.MitchellS. A. T.KuskowskiM. A.MantyhP. W. (2018). Anti–nerve growth factor does not change physical activity in normal young or aging mice but does increase activity in mice with skeletal pain. Pain159, 2285–2295. doi: 10.1097/j.pain.0000000000001330
34
MatsonD. J.BroomD. C.CarsonS. R.BaldassariJ.KehneJ.CortrightD. N. (2007). Inflammation-Induced Reduction of Spontaneous Activity by Adjuvant: A Novel Model to Study the Effect of Analgesics in Rats. J. Pharmacol. Exp. Ther.320, 194–201. doi: 10.1124/jpet.106.109736
35
MensW. B.WitterA.van Wimersma GreidanusT. B. (1983). Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res.262, 143–149. doi: 10.1016/0006-8993(83)90478-x
36
MestreC.PélissierT.FialipJ.WilcoxG.EschalierA. (1994). A method to perform direct transcutaneous intrathecal injection in rats. J. Pharmacol. Toxicol. Methods32, 197–200. doi: 10.1016/1056-8719(94)90087-6
37
Miranda-CardenasY.Rojas-PiloniG.Martínez-LorenzanaG.Rodríguez-JiménezJ.López-HidalgoM.Freund-MercierM. J.et al. (2006). Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist. Pain122, 182–189. doi: 10.1016/j.pain.2006.01.029
38
NeumannI. D.SlatteryD. A. (2016). Oxytocin in General Anxiety and Social Fear: A Translational Approach. Biol. Psychiatry79, 213–221. doi: 10.1016/j.biopsych.2015.06.004
39
ParentA. J.BeaudetN.BeaudryH.BergeronJ.BérubéP.DroletG.et al. (2012). Increased Anxiety-Like Behaviors in Rats Experiencing Chronic Inflammatory Pain. Behav. Brain Res.229, 160–167. doi: 10.1016/j.bbr.2012.01.001
40
PerkinsF. M.KehletH. (2000). Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology93, 1123–1133. doi: 10.1097/0000054220001000000038
41
PogatzkiE. M.RajaS. N. (2003). A mouse model of incisional pain. Anesthesiology99, 1023–1027. doi: 10.1097/00000542-200310000-00041
42
PogatzkiE. M.GebhartG. F.BrennanT. J. (2002). Characterization of Aδ- and C-Fibers Innervating the Plantar Rat Hindpaw One Day After an Incision. J. Neurophysiol.87, 721–731. doi: 10.1152/jn.00208.2001
43
PoisbeauP.GrinevichV.CharletA. (2018). Oxytocin Signaling in Pain: Cellular, Circuit, System, and Behavioral Levels. Curr. Top. Behav. Neurosci.35, 193–211. doi: 10.1007/7854_2017_14
44
ReddiD. (2016). Preventing chronic postoperative pain. Anaesthesia71 Suppl 1, 64–71. doi: 10.1111/anae.13306
45
ReetaKH.MedirattaP. K.RathiN.JainH.ChughC.SharmaK. K. (2006). Role of κ- and δ-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice. Regul. Pept.135, 85–90. doi: 10.1016/j.regpep.2006.04.004
46
RingR. H.MalbergJ. E.PotestioL.PingJ.BoikessS.LuoB.et al. (2006). Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacol.185, 218–225. doi: 10.1007/s002130050293-z
47
RoughanJ. V.Wright-WilliamsS. L.FlecknellP. A. (2009). Automated analysis of postoperative behaviour: assessment of HomeCageScan as a novel method to rapidly identify pain and analgesic effects in mice. Lab. Anim.43, 17–26. doi: 10.1258/la.2008.007156
48
RuscheweyhR.Wilder-SmithO.DrdlaR.LiuX. G.SandkühlerJ. (2011). Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol. Pain7, 20. doi: 10.1186/1744-8069-7-20
49
SeibenhenerM. L.WootenM. C. (2015). Use of the Open Field Maze to Measure Locomotor and Anxiety-like Behavior in Mice. J. Vis. Exp.96, 52434. doi: 10.3791/52434
50
SunW.ZhouQ.BaX.FengX.HuX.ChengX.et al. (2018). Oxytocin relieves neuropathic pain through GABA release and presynaptic TRPV1 inhibition in spinal cord. Front. Mol. Neurosci.11, 248. doi: 10.3389/fnmol.2018.00248
51
TaatiM.TamaddonfardE. (2018). Ventrolateral orbital cortex oxytocin attenuates neuropathic pain through periaqueductal gray opioid receptor. Pharmacol. Rep.70, 577–583. doi: 10.1016/j.pharep.2017.12.010
52
UrbanR.ScherrerG.GouldingE. H.TecottL. H.BasbaumA.II (2011). Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain152, 990–1000. doi: 10.1016/j.pain.2010.12.003
53
VandermeulenE. P.BrennanT. J. (2000). Alterations in ascending dorsal horn neurons by a surgical incision in the rat foot. Anesthesiology93, 1294–1302; discussion 6A. doi: 10.1097/00000542-200011000-00024
54
WeiserT. G.RegenbogenS. E.ThompsonK. D.HaynesA. B.LipsitzS. R.BerryW. R.et al. (2008). An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet372, 139–144. doi: 10.1016/S01406736(08)60878-8
55
WeiserT. G.HaynesA. B.MolinaG.LipsitzS. R.EsquivelM. M.Uribe-LeitzT.et al. (2015). Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet385, S11. doi: 10.1016/S01406736(15)60806-6
56
WeiserT. G.HaynesA. B.MolinaG.LipsitzS. R.EsquivelM. M.Uribe-LeitzT.et al. (2016). Size and distribution of the global volume of surgery in 2012. Bull. World Health Organ.94, 201–209F. doi: 10.2471/BLT.15.159293
57
YasenkovR.DeboerT. (2012). Circadian modulation of sleep in rodents. Prog. Brain Res.199, 203–218. doi: 10.1016/B9780444594273.00012-5
58
YehudaS.Leprohon-GreenwoodC. E.DixonL. M.CoscinaD. V. (1986). Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol. Biochem. Behav.24, 1775–1777. doi: 10.1016/0091-3057(86)90519-8
59
YuS.-Q.LundebergT.YuL.-C. (2003). Involvement of oxytocin in spinal antinociception in rats with inflammation. Brain Res.983, 13–22. doi: 10.1016/S00068993(03)03019-1
Summary
Keywords
hyperalgesia, oxytocin, postoperative pain, evoked pain, spontaneous pain, allodynia, anxiety
Citation
Espinosa De Los Monteros-Zúñiga A, Martínez-Lorenzana G, Condés-Lara M and González-Hernández A (2020) Intrathecal Oxytocin Improves Spontaneous Behavior and Reduces Mechanical Hypersensitivity in a Rat Model of Postoperative Pain. Front. Pharmacol. 11:581544. doi: 10.3389/fphar.2020.581544
Received
09 July 2020
Accepted
31 August 2020
Published
16 September 2020
Volume
11 - 2020
Edited by
Paolo Tonin, Sant’Anna Institute, Italy
Reviewed by
Claudia Cristiano, University of Naples Federico II, Italy; Anna Maria Pittaluga, University of Genoa, Italy
Updates
Copyright
© 2020 Espinosa De Los Monteros-Zúñiga, Martínez-Lorenzana, Condés-Lara and González-Hernández.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Abimael González-Hernández, abimaelgh@comunidad.unam.mx
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.